These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

77 related items for PubMed ID: 3042186

  • 1. Beneficial effects of the peptidoleukotriene receptor antagonist, SK&F 104353, on the responses to experimental endotoxemia in the conscious rat.
    Smith EF, Kinter LB, Jugus M, Wasserman MA, Eckardt RD, Newton JF.
    Circ Shock; 1988 May; 25(1):21-31. PubMed ID: 3042186
    [Abstract] [Full Text] [Related]

  • 2. Concentration-dependent, stereoselective inhibition of the endotoxin-induced hemoconcentration in conscious rats with the peptidoleukotriene receptor antagonist SK & F 104353.
    Smith EF, Kinter LB, Jugus M, Eckardt RD, Newton JF.
    Eicosanoids; 1989 May; 2(2):101-7. PubMed ID: 2560662
    [Abstract] [Full Text] [Related]

  • 3. Antagonism of leukotriene C4, leukotriene D4 and leukotriene E4 vasoconstrictor responses in the conscious rat with the peptidoleukotriene receptor antagonist SK&F 104353: evidence for leukotriene D4 receptor heterogeneity.
    Smith EF, Slivjak MJ, Eckardt RD, Newton JF.
    J Pharmacol Exp Ther; 1989 Jun; 249(3):805-11. PubMed ID: 2543811
    [Abstract] [Full Text] [Related]

  • 4. Effect of the thrombolytic agent, streptokinase, on the responses to endotoxemia in conscious rats.
    Smith EF, Kinter LB, Jugus M, Zeid R.
    Circ Shock; 1988 Jun; 25(2):85-94. PubMed ID: 3292078
    [Abstract] [Full Text] [Related]

  • 5. The bronchopulmonary pharmacology of SK&F 104353 in anesthetized guinea pigs: demonstration of potent and selective antagonism of responses to peptidoleukotrienes.
    Torphy TJ, Newton JF, Wasserman MA, Vickery-Clark L, Osborn RR, Bailey LS, Yodis LA, Underwood DC, Hay DW.
    J Pharmacol Exp Ther; 1989 May; 249(2):430-7. PubMed ID: 2542530
    [Abstract] [Full Text] [Related]

  • 6. Protective effect of a selective leukotriene antagonist in endotoxemia in the rat.
    Cook JA, Wise WC, Halushka PV.
    J Pharmacol Exp Ther; 1985 Nov; 235(2):470-4. PubMed ID: 2997435
    [Abstract] [Full Text] [Related]

  • 7. Effect of a selective V1 vasopressin receptor antagonist on the sequelae of endotoxemia in the conscious rat.
    Egan JW, Jugus M, Kinter LB, Lee K, Smith EF.
    Circ Shock; 1989 Oct; 29(2):155-66. PubMed ID: 2684446
    [Abstract] [Full Text] [Related]

  • 8. SK&F 104353: selective antagonism of peptidoleukotrine-induced changes in electrolyte transport by rat ileal mucosa in vitro.
    Elton E, Chiossone DC, McCafferty GP, Ryan FM, Smith PL.
    J Pharmacol Exp Ther; 1989 Nov; 251(2):484-9. PubMed ID: 2553922
    [Abstract] [Full Text] [Related]

  • 9. Cardiovascular and pulmonary effects of human recombinant tumor necrosis factor in the conscious rat.
    Turner CR, Esser KM, Wheeldon EB, Slivjak M, Smith EF.
    Circ Shock; 1989 Aug; 28(4):369-84. PubMed ID: 2673572
    [Abstract] [Full Text] [Related]

  • 10. Effect of LTB4 receptor antagonists in endotoxic shock in the rat.
    Li EJ, Cook JA, Wise WC, Jackson WT, Halushka PV.
    Circ Shock; 1991 Aug; 34(4):385-92. PubMed ID: 1663429
    [Abstract] [Full Text] [Related]

  • 11. Effect of leukotriene receptor antagonists on vascular permeability during endotoxic shock.
    Cook JA, Li EJ, Spicer KM, Wise WC, Halushka PV.
    Circ Shock; 1990 Nov; 32(3):209-18. PubMed ID: 2175680
    [Abstract] [Full Text] [Related]

  • 12. SK&F S-106203 inhibits leukotriene C4, leukotriene D4 and leukotriene E4 vasopressor responses in the conscious rat.
    Smith EF, Slivjak MJ, Egan JW, Eckardt RD, Newton JF.
    Br J Pharmacol; 1990 Jun; 100(2):195-200. PubMed ID: 2165834
    [Abstract] [Full Text] [Related]

  • 13. Effect of the thromboxane receptor antagonist, BM 13.505, on the sequelae of endotoxemia in the conscious rat.
    Smith EF, Jugus M, Kinter LB.
    Eicosanoids; 1988 Jun; 1(1):27-33. PubMed ID: 3078574
    [Abstract] [Full Text] [Related]

  • 14. Beneficial effects of a leukotriene antagonist on endotoxin-induced acute hemodynamic alterations.
    Etemadi AR, Tempel GE, Farah BA, Wise WC, Halushka PV, Cook JA.
    Circ Shock; 1987 Jun; 22(1):55-63. PubMed ID: 3038364
    [Abstract] [Full Text] [Related]

  • 15. Beneficial effects of a specific leukotriene receptor antagonist in splanchnic artery occlusion shock.
    Lento PH, Saukkonen K, Aoki N, Lefer AM, Slivjak MJ, Smith EF.
    Eur J Pharmacol; 1989 Jun 20; 165(2-3):241-9. PubMed ID: 2550251
    [Abstract] [Full Text] [Related]

  • 16. Resistance of essential fatty acid-deficient rats to endotoxin-induced increases in vascular permeability.
    Li EJ, Cook JA, Spicer KM, Wise WC, Rokach J, Halushka PV.
    Circ Shock; 1990 Jun 20; 31(2):159-70. PubMed ID: 2188748
    [Abstract] [Full Text] [Related]

  • 17. Attenuation of endotoxin-induced increase in glucose metabolism by platelet-activating factor antagonist.
    Lang CH, Dobrescu C, Hargrove DM, Bagby GJ, Spitzer JJ.
    Circ Shock; 1987 Jun 20; 23(3):179-88. PubMed ID: 3427772
    [Abstract] [Full Text] [Related]

  • 18. Therapeutic intervention in a rat model of adult respiratory distress syndrome: II. Lipoxygenase pathway inhibition.
    Turner CR, Lackey MN, Quinlan MF, Griswold DE, Schwartz LW, Wheeldon EB.
    Circ Shock; 1991 Jun 20; 34(2):263-9. PubMed ID: 1934327
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.